Virginia will cap hemp products at two milligrams of total THC per package on August 15 while preparing adult-use stores that can sell ten milligrams per serving and one hundred milligrams per package. Seven hemp businesses are suing, and the contradiction exposes a market boundary dressed as dose control.
Texas Starts the THC Countdown
Texas Starts the THC Countdown explains how the Texas Supreme Court and DSHS turned Delta-8 and similar affected hemp-derived THC products into a July 31 shelf problem. Texas let consumers and retailers treat hemp THC like normal retail, then used schedules, definitions, and agency pressure to make legality feel temporary.
Australia Splits on the THC Driving Lie
Australia’s THC driving laws are split over medical cannabis, impairment, and roadside testing. New South Wales is moving toward a narrow patient carveout, while Queensland is doubling down on zero-tolerance enforcement. Pot Culture Magazine explains how legal medicine becomes a license trap when THC residue is treated like proof of danger.
The THC Number Broke Weed
THC percentage became the shortcut that broke cannabis literacy. Prohibition used cannabis potency to scare the public, while the legal market used THC numbers to sell flower. The result is a culture trained to chase one percentage while ignoring cure, freshness, balance, testing integrity, and the person consuming the plant.
CANNABIS LIES Vol. 6: The Driving Apocalypse Lie
Legal cannabis is often blamed for rising traffic deaths, but federal data tells a more complicated story. NHTSA findings, toxicology limitations, and conflicting crash studies reveal that THC presence is not a reliable measure of impairment. This investigation breaks down how flawed testing and policy shortcuts have shaped the narrative around so-called stoned driving.
Texas Is Moving to Shut Down the Hemp Market
Texas helped build one of the largest hemp THC markets in the country, then moved to shut it down. As regulators tighten rules and enforcement increases, businesses are left exposed, and the future of hemp-derived cannabinoids hangs in the balance. This is not a simple crackdown. It is a full policy reversal with real economic consequences.